11:08 pm
Thu August 22, 2013

New Hope for Alzheimer's Disease Drug

TransTech Pharma drug aimed at delaying onset of Alzheimer's disease is headed toward phase 3 testing.
Credit epSos vis flickr

The incidence of the mysterious and devastating Alzheimer's disease continues to rise in the U-S.  Justin Catanoso, Business Journal contributing writer and director of Wake Forest University's journalism program,  discusses a Triad company's new drug with potential to delay the onset of Alzheimer's.

Read more
8:41 am
Fri December 7, 2012

Bright Ideas in Development in the Triad

Wake Forest University physics professor David Carroll works with graduate student on new FIPEL lighting technology.
Credit Photo courtesy of Wake Forest University

One organization plans to ramp up production of a  new light source, while a new startup seeks to work on new drugs that could help people suffering from Parkinson's Disease and addictions. Justin Catanoso, contributing writer with the Triad Business Journal and director of Wake Forest University's journalism program, discusses these developments with WFDD's Audrey Fannin.  

Read more